JPMORGAN CHASE & CO - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 217 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.74 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$26,880,000
+7224.3%
1,494,183
+2798.6%
0.01%
Q1 2020$367,000
-90.9%
51,549
-69.5%
0.00%
-100.0%
Q4 2019$4,031,000
+209.8%
168,757
+247.9%
0.00%
Q3 2019$1,301,000
-92.7%
48,501
-92.7%
0.00%
-100.0%
Q2 2019$17,835,000
-57.9%
668,232
-45.3%
0.00%
-66.7%
Q1 2019$42,362,000
+201.2%
1,220,785
+69.4%
0.01%
+200.0%
Q4 2018$14,064,000
-23.0%
720,455
+5.0%
0.00%0.0%
Q3 2018$18,270,000
-22.1%
686,079
+10.5%
0.00%
-40.0%
Q2 2018$23,451,000
+7.1%
620,889
-7.4%
0.01%0.0%
Q1 2018$21,891,000
-30.8%
670,274
+3.1%
0.01%
-28.6%
Q4 2017$31,655,000
-21.0%
650,264
-12.7%
0.01%
-22.2%
Q3 2017$40,081,000
-0.6%
744,702
+3.7%
0.01%0.0%
Q2 2017$40,340,000
-3.3%
718,158
-32.5%
0.01%
-10.0%
Q1 2017$41,705,000
+49.2%
1,064,192
-14.6%
0.01%
+42.9%
Q4 2016$27,958,000
-2.6%
1,245,920
-1.4%
0.01%0.0%
Q3 2016$28,709,000
-7.3%
1,264,155
-3.7%
0.01%
-12.5%
Q2 2016$30,968,000
+16.9%
1,312,188
+1.1%
0.01%
+14.3%
Q1 2016$26,481,000
-33.3%
1,298,116
+68.3%
0.01%
-30.0%
Q4 2015$39,684,000
+1.2%
771,299
-16.2%
0.01%0.0%
Q3 2015$39,227,000
-7.0%
920,405
-0.6%
0.01%0.0%
Q2 2015$42,184,000
+17.3%
926,126
-2.2%
0.01%
+25.0%
Q1 2015$35,960,000
+18.2%
947,338
-11.8%
0.01%
+14.3%
Q4 2014$30,422,000
-2.1%
1,074,210
-12.6%
0.01%0.0%
Q3 2014$31,085,000
-19.2%
1,229,596
-6.7%
0.01%
-30.0%
Q2 2014$38,475,000
+10.7%
1,318,553
-1.7%
0.01%0.0%
Q1 2014$34,751,000
+29.6%
1,341,756
+28.8%
0.01%
+25.0%
Q4 2013$26,817,0001,041,4330.01%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders